Results

Total Results: over 10,000 records

Showing results for "weight".
Users also searched for: obesity screening

  1. hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2006_MaskedStats_IP.PDF
    January 01, 2006 - Means of Continuous Data Elements Variable / Label N N Miss Minimum Maximum Mean Std Dev DISCWT : Weight … :13 Friday, June 19, 2009 31 Univariates of Selected Continuous Data Elements Variable: DISCWT (Weight … :13 Friday, June 19, 2009 31 Univariates of Selected Continuous Data Elements Variable: DISCWT (Weight
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
    September 28, 2015 - TEP 1 General The analyses included the change (primarily) in A1c and body weight at 12/24 months. … typically change in A1c, while the main outcome in a lifestyle intervention is typically change in weight
  3. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_1997_SummaryStats_CORE.PDF
    January 01, 1997 - please refer to the section on Description of Data Elements. For more information about the coding of HCUP data elements, HCUP Summary Statistics Report: KID 1997 - CORE File 1 Means of Continuous Data Elements 14:38 Monday, May 8, 2006 please refer to the section on Description of Data Elements. For more informatio…
  4. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary9/alcohol-misuse-screening-and-behavioral-counseling-interventions-in-primary-care-2013
    September 25, 2012 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Alcohol Misuse: Screening and Behavioral Counseling Interventions in Primary Care September 25, 2012 Recommendations made by the USPSTF are independen…
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/-KMSTWRT9xbm7spaqDq_GE
    February 12, 2019 - symptoms,39 mental health treatment,40 breastfeeding,38 child development,49 child attachment,49 birth weight … and preterm birth.42 Of these, 1 trial (n = 184) showed statistically significant ben- efits on birth weight
  6. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and weight loss … The company also reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18) than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body weight from baseline to week 12 24 were observed in both groups … Several experts noted that subcutaneous exenatide use would also result in effective weight loss.
  7. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and weight loss … The company also reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18) than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body weight from baseline to week 12 24 were observed in both groups … Several experts noted that subcutaneous exenatide use would also result in effective weight loss.
  8. Diabetes Mellitus (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and weight loss … The company also reported that the drug led to reduced body weight after 24 and 48 weeks of treatment … Subjects taking Lira lost more weight (-3.58 kg, SE 0.18) than those taking EQW (-2.68 kg, SE 0.18; … Similar reductions in mean body weight from baseline to week 12 24 were observed in both groups … Several experts noted that subcutaneous exenatide use would also result in effective weight loss.
  9. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes
    April 13, 2015 - Individual lifestyle counseling session aimed at decreasing body weight and increasing physical activity … Intensive lifestyle intervention, including diet and exercise to achieve modest weight reduction (n=1,048 … Individual session and goal to decrease weight by 5% with follow up at 1, 3, 6, 12, 18, 24, 30, and 36 … months (n=330) B. 1 session of advice to reduce weight by 5% (n=311) Patients with IGT and BMI … Lifestyle counseling, including weight loss 7% over 3 months, diet information, walking 30 minutes per
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
    July 15, 2007 - children include dietary supplements (fiber, sterol or stanol margarines, omega-3 fatty acids), exercise, weight … studies reported normal height growth, 170 , 190 , 234-236 , 239 , 240 , 242 , 243 , 245-247 although weight … 37% 650 20 specificity calculated 1,005, ages 2-13, 8 office practices Overweight (weight … 90th percentile 57% NR N/A 42   1,005, ages 2-13, 8 office practices Overweight (weight … Abdominal pain (3), chest pain (1), flatulence (1), myalgia (2), headache (4), sleep disorder (1), weight
  11. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary25/screening-for-abnormal-blood-glucose-and-type-2-diabetes-october-2015
    April 13, 2015 - Individual lifestyle counseling session aimed at decreasing body weight and increasing physical activity … Intensive lifestyle intervention, including diet and exercise to achieve modest weight reduction (n=1,048 … Individual session and goal to decrease weight by 5% with follow up at 1, 3, 6, 12, 18, 24, 30, and 36 … months (n=330) B. 1 session of advice to reduce weight by 5% (n=311) Patients with IGT and BMI … Lifestyle counseling, including weight loss 7% over 3 months, diet information, walking 30 minutes per
  12. cds.ahrq.gov/taxonomy/term/69806
    August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  13. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/atrial-fibrillation-screening-with-electrocardiography
    August 07, 2018 - (KQ4) Weights are from random-effects meta-analysis; size of data markers indicates the weight … (KQ5) Weights are from random-effects meta-analysis; size of data markers indicates the weight
  14. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  15. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  16. www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  17. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  18. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  19. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight
  20. ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
    July 01, 2016 - hyperactivity Administrative m • • • disorder (ADHD) medication Care of acute and chronic conditions Weight